Cencora

Cencora, a company building on the legacy of AmerisourceBergen, is a global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect our pharmaceutical partners, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes.

Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 46,000+ worldwide team members are shaping the future of healthcare through the power our purpose: We are united in our responsibility to create healthier futures.

AmerisourceBergen, now Cencora, is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $230 billion in annual revenue.

Headquartered in Valley Forge, Pennsylvania, AmerisourceBergen has locations around the world. It handles about 20% of all of the pharmaceuticals sold and distributed throughout the U.S.

They strive to take costs out of the healthcare system by using their scale and efficient operations to drive value for their customers. In addition to delivering pharmaceuticals on a just-in-time basis to tens of thousands of healthcare providers every day, they provide business support and consulting services to help their customers focus on their key strength—caring for patients.

AmerisourceBergen is committed to the safety and security of the nation’s pharmaceutical supply chain. They purchase all branded and generic pharmaceuticals only directly from the product’s manufacturer, except in the rare instance that they are required to do otherwise either by the manufacturer or a government agency.

Cencora, established in 2023 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Pharmaceutical, Health Care, Medical, Hospital, Financial Services, Venture Capital, Finance, Incubators, Wellness, Enterprise Software. The organization boasts a portfolio of 7 investments, with an average round size of $11.3M and 2 successful exits. Their recent investments include Profarma, Sempre Health, Industry Ventures, Echo Health Ventures, The Blue Venture Fund. The highest investment round they participated in was $2.5B. Among their most notable exits are Profarma and Sempre Health. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.